|
Co-Founder, Dr. Zahradnik was appointed President and CEO of Oragenics, Inc. in September 2005. Previously, he conducted dental research sponsored by the National Institute of Health at the Forsyth Dental Center in Boston throughout the 1970s, during which he authored or co-authored more than 25 original publications. Since 1980, he has been involved with various levels of product management, initially at Johnson & Johnson, and during the past 19 years as president of Advanced Clinical Technologies, Inc., a research and development company that he founded in 1986. Dr. Zahradnik holds several patents related to oral pharmaceuticals and diagnostics. He also co-founded Pro-Dentec Therapeutics, a company that manufactures oral pharmaceuticals. Dr. Zahradnik received his undergraduate degree from Penn State University and his PhD degree from Boston University. | 